Epidemiology of traumatic spinal cord injury: a comparative study of anxiety or depression incidence between 2000 and 2009 and 2010–2019 Authors: Te-Kai Liao, Hsuan-Yi Huang, Ying-Jia Lin, Chung-Han Ho, Jhi-Joung Wang, Fu-Wen Liang, Hsiao-Hsuan Chou, Sher-Wei Lim Published: 2025 ABSTRACT BackgroundAnxiety and depression are prevalent psychological consequences following patients with traumatic spinal cord injury (tSCI). This study aims to estimate within-cohort temporal changes to compare the incidence of anxiety or depression among tSCI patients between two decades (2000–2009 and 2010–2019).MethodsA retrospective cohort study of hospitalized tSCI patients (n = 4,960) used to compare the incidence of anxiety or depression within three years post-tSCI between the two decades. Incidence rate ratios (IRR) was estimated using Poisson regression, and Cox regression was assessed the relative risk with adjustment of age, sex, comorbidities, Charlson Comorbidity Index (CCI), and Catastrophic Illness Card status.ResultsThe incidence rate of anxiety or depression significantly increased from 208.46 to 350.44 per 10,000 person-years (IRR = 1.68, 95% CI: 1.35–2.08, p < 0.0001). The highest increase was among patients aged 20–34 years (IRR = 1.90, 95% CI: 1.12–3.22, p = 0.0176). Adjusted Cox regression showed that tSCI patients from 2010 to 2019 had a higher risk of anxiety or depression (AHR = 1.67, 95% CI: 1.33–2.08, p < 0.0001) than those from 2000 to 2009. The risk was particularly elevated among younger patients, those without a catastrophic illness card (AHR = 1.71, p < 0.0001), and those with lower CCI scores (CCI = 0, AHR = 1.77, p = 0.0003; CCI = 1–2, AHR = 1.79, p = 0.0026).ConclusionsThis study indicated an increasing anxiety or depression in tSCI patients, especially among younger adults and those without catastrophic illness status. Early psychiatric screening, multidisciplinary care, and psychosocial support are critical to improving long-term outcomes. Introduction Traumatic spinal cord injury (tSCI) is a life-altering condition that carries significant physical, psychological, and social implications, often resulting in profound neurological impairment and reduced quality of life [1]. The primary etiologies of SCI include motor vehicle accidents, sports-related injuries, falls, and gunshot wounds, which collectively account for the majority of spinal cord injuries compared to non-traumatic causes such as tumors and infections [2, 3]. Advances in medical care have improved survival rates; however, SCI survivors continue to face substantial challenges, including heightened risks of mental health disorders. Depression and anxiety are prevalent psychological consequences following tSCI, with depression typically receiving more attention in research. However, anxiety may be equally consequential in SCI patients, as it influences post-injury functioning and overall quality of life [4, 5]. Previous research suggests that the risk of developing depression or anxiety may be similar among SCI patients, regardless of the severity or level of injury [6]. Our prior study also indicated that tSCI patients have a high risk of anxiety or depression in post-discharge, especially among the younger tSCI patients (age < 50 years) [7]. Although debates about depression and anxiety prevalence persist in the general population [8–10], they are not the main concern for tSCI research. Over the past decades, an aging population and a rising burden of chronic diseases may further increase the risk of psychological disorders in this population [11, 12]. Although there is growing recognition of the mental health burden in the tSCI patients, research remains limited on how temporal shifts in demographics and clinical characteristics affect anxiety and depression across different healthcare eras. Especially, population-level prevalence and incidence of depression and anxiety have changed over recent decades with complex demographic and societal factors. Therefore, this study aimed to investigate the epidemiological characteristics, comorbidities, and within-cohort temporal changes in anxiety and depression among patients with tSCI between 2000 and 2009 and 2010–2019. The objective was to analyze trends and risk factors to better understand the mental health challenges faced by tSCI population over two decades. The findings may provide evidence to inform interventions aimed at improving long-term rehabilitation and mental health outcomes. Methods Data source This retrospective cohort study used the longitudinal National Health Insurance Research Database 2005 (LHID2005), provided by the Health and Welfare Data Science Center (HWDC) of the Ministry of Health and Welfare in Taiwan. LHID2005 is a subset database of Taiwan’s National Health Insurance Research Database (NHIRD), which is maintained by the Bureau of National Health Insurance (BNHI) and covers about 99% of the country’s inpatient and outpatient medical benefits. LHID2005 is a random sample of two million individuals from 2005. It is designed to reflect the demographic characteristics of Taiwan in terms of gender, age, and regional distribution. Additionally, although the sample was drawn in 2005, the dataset contains longitudinal healthcare information for the included individuals across the entire study period. Study population and study design This study included hospitalized patients diagnosed with tSCI between 2000 and 2019 to compare the incidence of depression and anxiety across two time periods (2000–2009 vs. 2010–2019). Patients with tSCI was defined using ICD-9-CM codes (806 and 952) and ICD-10-CM codes (S14.101 A-S14.159 A, S24.101 A-S24.159 A, and S34.101 A-S34.139 A). A total of 6069 patients were initially enrolled in this study. The exclusion criteria included patients who aged less than 20 years, patients with a pre-existing anxiety or depression diagnosis before diagnosis of tSCI, patients who sustained tSCI after obtaining a Catastrophic Illness Card, or mental disease occurs within a month. Additionally, to reduce the potential protopathic bias, patients diagnosed with anxiety or depression within one month after tSCI were also excluded to avoid the transient post-injury stress responses [13, 14]. Finally, 4931 tSCI patients remained in the study. The selection of study subjects presented as Fig. 1.Fig. 1Flow chart of study participants selection Flow chart of study participants selection Additionally, this study used a retrospective within-cohort temporal design focusing on patients with tSCI. A within-cohort temporal design compares outcomes across different time periods within the same patient population for reducing confounding from inter-cohort differences [15, 16]. This approach was suitable for our study aim to compare the incidence and risk factors of anxiety and depression between two decades within the tSCI population. As our previous research has demonstrated that patients with tSCI have a higher risk of developing anxiety or depression compared with the general population [7], the current study was designed to explore how this psychological burden has changed over time within the tSCI cohort. Outcome and measurements The primary outcome of this study was to compare the incidence of depression or anxiety among patients with tSCI between the 2000–2009 and 2010–2019 cohorts. Depression or anxiety disorders are identified using ICD-9-CM codes (309.2–309.4.2.4, 296.2, 296.5, 296.82, 300.4, 309.0–309.1.0.1, 311) and ICD-10-CM codes (F31.31-F31.32, F31.75-F31.29, F31.76, F31.4-F31.5, F32, F34.1, F41, F43.21-F43.25, F43.29) based on the outpatient or inpatient records within three years post-tSCI. A three-year follow-up period was selected because previous studies have shown that the risk of developing depression or anxiety is highest during the first three years following tSCI [17, 18]. Patients may face the most serious physical, psychological, and social adjustments [5, 19]. Additionally, this duration could help minimize potential duration bias by focusing on early-onset psychological disorders most likely related to tSCI. Additionally, due to the high comorbidity and overlapping symptoms between depression and anxiety following tSCI [20, 21], these two disorders were analyzed as a composite outcome to better reflect the overall affective morbidity in this population. This approach is consistent with previous NHIRD-based research [7, 22]. To estimate the incidence rate of depression or anxiety, potential confounding factors were also assessed, such as age, sex, Catastrophic Illness Card status, Charlson Comorbidity Index (CCI) score, hypertension (HTN), diabetes mellitus (DM), and coronary artery disease (CAD). The Catastrophic Illness Card is a Taiwan’s government-issued designation for patients with severe conditions, verified through physician certification and medical history review. Since tSCI patients who qualify for a Catastrophic Illness Card meet the criteria for catastrophic injury (Injury Severity Score, ISS ≥ 16), the Catastrophic Illness Card serves as a reliable proxy for defining severe SCI in this study. Comorbidities and CCI scores were determined based on at least one inpatient or outpatient records before the diagnosis date of tSCI based on the ICD-9-CM and ICD-10-CM codes. The CCI was used to assess the severity of comorbid conditions in tSCI patients. The CCI used weighted scores to 17 medical conditions, with higher scores indicating greater disease burden [23, 24]. This index allows for standardized comparisons across study periods and accounts for underlying health conditions that may affect anxiety and depression. Statistics analysis Descriptive statistics were used to examine the baseline distribution of data between the 2000–2009 and 2010–2019 cohorts. Categorical variables, including age, sex, Catastrophic Illness Card status, CCI score, comorbidities, and the presence of anxiety or depression, were analyzed using the Pearson’s chi-square test. The incidence rate of anxiety or depression was calculated per 10,000 person-years as the number of cases divided by the total person-years. The incidence rate ratio (IRR) of anxiety or depression and the 95% confidence interval (CI) was estimated using Poisson regression for each interested variables between these two cohorts. Additionally, the trend of cumulative incidence of anxiety or depression between two periods was plotted Kaplan–Meier curves with log-rank test for comparing the difference. The relative risk of developing anxiety or depression was assessed using Cox regression analysis adjusted with age, sex, CCI score, Catastrophic Illness Card status, and comorbidities. Both Poisson and Cox regression models were used to provide complementary perspectives on risk estimation. Poisson regression was used to compare population-level incidence rates between decades, and Cox regression was used to estimate individual-level time-to-event risk after adjusting for potential confounders. The subgroup analysis of different sex, age group, catastrophic illness card, and level of CCI score was illustrated using forest plot to present the risk ratio of anxiety or depression between two cohorts. All statistical analysis were conducted using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC, USA), and the statistical significance was set as p-value < 0.05. Results Table 1 shows the baseline characteristics between the tSCI from 2000 to 2009 (n = 2843) and 2010–2019 (n = 2088). Significant differences were observed between the two decades in age distribution (p < 0.0001), with a decrease in younger patients (20–49 years) and an increase in older patients (≥ 50 years), indicating an aging trend in the tSCI population. The proportion of male patients was also significantly higher in 2010–2019 than in 2000–2009 (69.78% vs. 63.14%, p < 0.0001). The prevalence of comorbidities, including HTN (p < 0.0001), DM(p < 0.0001) and CCI score(p < 0.0001), increased significantly in the later decade. Additionally, the incidence of anxiety or depression was significantly higher in the 2010–2019 cohort (8.05% vs. 5.73%, p = 0.0013). However, the time to onset of anxiety or depression did not significantly differ between the two groups (p = 0.1170). Table 1The baseline characteristics between patients with tSCI from 2000–2009 and 2010–2019tSCI year: 2000–2009(n = 2843)tSCI year: 2010–2019(n = 2088)p-valueAge group, n(%) 20–34612(21.53)275(13.17)< 0.0001 35–49805(28.32)413(19.78) 50–64657(23.11)742(35.54) ≥ 65769(27.05)658(31.51)Sex, n(%) Male1795(63.14)1457(69.78)< 0.0001 Female1048(36.86)631(30.22)Catastrophic Illness Card, n(%) No2590(91.10)1964(94.06)0.0001 Yes253(8.90)124(5.94)Comorbidity, n(%) HTN644(22.65)722(34.58)< 0.0001 DM325(11.43)418(20.02)< 0.0001 CAD248(8.72)213(10.20)0.0782 Liver disease275(9.67)195(9.34)0.6933 Renal disease64(2.25)112(5.36)< 0.0001 COPD330(11.61)208(9.96)0.0670CCI score 01742(61.27)1131(54.17)< 0.0001 1,2810(28.49)622(29.79) >=3291(10.24)335(16.04)OutcomeAnxiety/depression, n(%)163(5.73)168(8.05)0.0013Time to anxiety/depression, years1.14 ± 0.841.24 ± 0.840.1170Abbreviations: tSCI traumatic spinal cord injury, HTN hypertension, DM diabetes mellitus, CAD coronary artery disease, COPD Chronic Obstruction Pulmonary Disease, CCI Charlson Comorbidity Index Table 1The baseline characteristics between patients with tSCI from 2000–2009 and 2010–2019tSCI year: 2000–2009(n = 2843)tSCI year: 2010–2019(n = 2088)p-valueAge group, n(%) 20–34612(21.53)275(13.17)< 0.0001 35–49805(28.32)413(19.78) 50–64657(23.11)742(35.54) ≥ 65769(27.05)658(31.51)Sex, n(%) Male1795(63.14)1457(69.78)< 0.0001 Female1048(36.86)631(30.22)Catastrophic Illness Card, n(%) No2590(91.10)1964(94.06)0.0001 Yes253(8.90)124(5.94)Comorbidity, n(%) HTN644(22.65)722(34.58)< 0.0001 DM325(11.43)418(20.02)< 0.0001 CAD248(8.72)213(10.20)0.0782 Liver disease275(9.67)195(9.34)0.6933 Renal disease64(2.25)112(5.36)< 0.0001 COPD330(11.61)208(9.96)0.0670CCI score 01742(61.27)1131(54.17)< 0.0001 1,2810(28.49)622(29.79) >=3291(10.24)335(16.04)OutcomeAnxiety/depression, n(%)163(5.73)168(8.05)0.0013Time to anxiety/depression, years1.14 ± 0.841.24 ± 0.840.1170Abbreviations: tSCI traumatic spinal cord injury, HTN hypertension, DM diabetes mellitus, CAD coronary artery disease, COPD Chronic Obstruction Pulmonary Disease, CCI Charlson Comorbidity Index The baseline characteristics between patients with tSCI from 2000–2009 and 2010–2019 Abbreviations: tSCI traumatic spinal cord injury, HTN hypertension, DM diabetes mellitus, CAD coronary artery disease, COPD Chronic Obstruction Pulmonary Disease, CCI Charlson Comorbidity Index The incidence rate of new-onset anxiety or depression between the tSCI cohorts in 2000–2009 and in 2010–2019 was compared as Table 2 for overall and stratified analysis. The overall incidence rate of anxiety or depression increased significantly from 208.46 to 350.44 per 10,000 person-years (IRR = 1.68, 95% CI: 1.35–2.08, p < 0.0001). Across age groups, the highest increase was observed in patients aged 20–34 years (IRR = 1.90, 95% CI: 1.12–3.22, p = 0.0176). Both males and females had significantly increased incidence rates in the later decade. Furthermore, compared with the 2000–2009 cohort, females with tSCI presented a higher incidence ratio (IRR: 1.73, 95%CI: 1.24–2.41, p = 0.0012) than males (IRR: 1.71, 95% CI: 1.29–2.27, p = 0.0002). Among patients without comorbidities (CCI = 0), those in the 2010–2019 cohort had a higher incidence ratio of anxiety or depression than those in 2000–2009 (IRR = 1.70, 95% CI: 1.26–2.31, p = 0.0006). Considering the adjusted confounding factors, the Cox proportional hazard analysis showed that patients with tSCI from 2010 to 2019 were more likely to develop anxiety or depression than those from 2000 to 2009 (adjusted hazard ratio, AHR: 1.67, 95% CI: 1.33–2.08, p < 0.0001). Additionally, the Kaplan-Meier plots showed that patients with tSCI from 2010 to 2019 had a significantly higher risk of new-onset anxiety or depression than those from 2000 to 2009 (log-rank test: p < 0.0001) (Fig. 2).Fig. 2The Kaplan-Meier plot of new-onset anxiety or depression incidence among patients with tSCI between 2000–2009 and 2010–2019 The Kaplan-Meier plot of new-onset anxiety or depression incidence among patients with tSCI between 2000–2009 and 2010–2019 Table 2Incidence rate for anxiety or depressiontSCI year: 2000–2009tSCI year: 2010–2019IRR(95% CI)p-valueAdjusted HR(95%CI)p-valueEventsPYRate*EventsPYRate*Overall1637819.17208.461684793.92350.441.68(1.35,2.08)< 0.00011.67(1.33,2.08)< 0.0001Age group 20–34321741.75183.7224687.94348.871.90(1.12,3.22)0.0176Ref 35–49472265.38207.47361013.04355.371.72(1.11,2.65)0.01491.03(0.73,1.45)0.8707 50–64361828.93196.84571748.02326.081.65(1.09,2.51)0.01810.87(0.61,1.23)0.4214 ≥65481983.11242.04511344.92379.201.57(1.06,2.32)0.02570.91(0.62,1.32)0.6066Sex Male894910.55181.241023293.09309.741.71(1.29,2.27)0.0002Ref Female742908.62254.42661500.83439.761.73(1.24,2.41)0.00121.41(1.13,1.77)0.0024Catastrophic Illness Card No1437128.71200.601544485.37343.341.71(1.36,2.15)< 0.0001Ref Yes20690.46289.6614308.55453.741.57(0.79,3.10)0.19781.51(1.05,2.16)0.0248CCI score 0864908.55175.20812715.15298.331.70(1.26,2.31)0.0006Ref 1,2552200.51249.94601416.96423.441.69(1.17,2.44)0.00481.36(1.01,1.83)0.0461 >=322710.11309.8127661.82407.971.32(0.75,2.31)0.33811.17(0.70,1.96)0.5443Comorbidity HTN461664.43276.37571523.54374.131.35(0.92,2.00)0.12661.05(0.79,1.41)0.7262 DM25840.92297.2933867.33380.481.28(0.76,2.15)0.35210.98(0.69,1.39)0.9051 CAD23639.91359.4315448.24334.640.93(0.49,1.78)0.82951.15(0.79,1.67)0.4621 Liver disease25707.64353.2917408.39416.271.17(0.63,2.17)0.60951.29(0.90,1.85)0.1740 Renal disease6141.30424.6313185.14702.171.65(0.63,4.35)0.30821.81(1.04,3.13)0.0345 COPD23861.78266.8913442.64293.691.10(0.56,2.18)0.77760.88(0.60,1.29)0.5178PY person-years*rate: per 10,000 person-yearsAbbreviations: tSCI traumatic spinal cord injury, IRR incidence rate ratios, CI confidence interval, AHR adjusted hazard ratio, HTN hypertension, DM diabetes mellitus, CAD coronary artery disease, COPD Chronic Obstruction Pulmonary Disease, CCI Charlson Comorbidity Index; Table 2Incidence rate for anxiety or depressiontSCI year: 2000–2009tSCI year: 2010–2019IRR(95% CI)p-valueAdjusted HR(95%CI)p-valueEventsPYRate*EventsPYRate*Overall1637819.17208.461684793.92350.441.68(1.35,2.08)< 0.00011.67(1.33,2.08)< 0.0001Age group 20–34321741.75183.7224687.94348.871.90(1.12,3.22)0.0176Ref 35–49472265.38207.47361013.04355.371.72(1.11,2.65)0.01491.03(0.73,1.45)0.8707 50–64361828.93196.84571748.02326.081.65(1.09,2.51)0.01810.87(0.61,1.23)0.4214 ≥65481983.11242.04511344.92379.201.57(1.06,2.32)0.02570.91(0.62,1.32)0.6066Sex Male894910.55181.241023293.09309.741.71(1.29,2.27)0.0002Ref Female742908.62254.42661500.83439.761.73(1.24,2.41)0.00121.41(1.13,1.77)0.0024Catastrophic Illness Card No1437128.71200.601544485.37343.341.71(1.36,2.15)< 0.0001Ref Yes20690.46289.6614308.55453.741.57(0.79,3.10)0.19781.51(1.05,2.16)0.0248CCI score 0864908.55175.20812715.15298.331.70(1.26,2.31)0.0006Ref 1,2552200.51249.94601416.96423.441.69(1.17,2.44)0.00481.36(1.01,1.83)0.0461 >=322710.11309.8127661.82407.971.32(0.75,2.31)0.33811.17(0.70,1.96)0.5443Comorbidity HTN461664.43276.37571523.54374.131.35(0.92,2.00)0.12661.05(0.79,1.41)0.7262 DM25840.92297.2933867.33380.481.28(0.76,2.15)0.35210.98(0.69,1.39)0.9051 CAD23639.91359.4315448.24334.640.93(0.49,1.78)0.82951.15(0.79,1.67)0.4621 Liver disease25707.64353.2917408.39416.271.17(0.63,2.17)0.60951.29(0.90,1.85)0.1740 Renal disease6141.30424.6313185.14702.171.65(0.63,4.35)0.30821.81(1.04,3.13)0.0345 COPD23861.78266.8913442.64293.691.10(0.56,2.18)0.77760.88(0.60,1.29)0.5178PY person-years*rate: per 10,000 person-yearsAbbreviations: tSCI traumatic spinal cord injury, IRR incidence rate ratios, CI confidence interval, AHR adjusted hazard ratio, HTN hypertension, DM diabetes mellitus, CAD coronary artery disease, COPD Chronic Obstruction Pulmonary Disease, CCI Charlson Comorbidity Index; Incidence rate for anxiety or depression PY person-years *rate: per 10,000 person-years Abbreviations: tSCI traumatic spinal cord injury, IRR incidence rate ratios, CI confidence interval, AHR adjusted hazard ratio, HTN hypertension, DM diabetes mellitus, CAD coronary artery disease, COPD Chronic Obstruction Pulmonary Disease, CCI Charlson Comorbidity Index; The subgroup analysis illustrated the risk of anxiety or depression between these two cohorts, stratified by sex, age group, with catastrophic illness card or not, and level of CCI score (Fig. 3). Our results indicated an increasing risk of anxiety or depression across various demographic groups in the more recent decade. Males and females both demonstrated a significantly increased risk. Younger patients (20–34 years) show the highest risk (AHR: 1.90, 95% CI: 1.10–3.27, p = 0.0209), followed by patients aged 35–49 years (AHR: 1.71, 95% CI: 1.10–2.67, p = 0.0173), 50–64 years (AHR: 1.71, 95% CI: 1.12–2.61, p = 0.0135) and older than 65 years (AHR: 1.54, 95% CI: 1.03–2.32, p = 0.0366). Additionally, tSCI patients without catastrophic illness card from 2010 to 2019 group were associated with a higher risk of new-onset anxiety or depression than those from 2000 to 2009 (AHR: 1.71, 95% CI: 1.35–2.16, p < 0.0001). Moreover, patients with CCI scores of 0 or 1–2 in 2010–2019 had a significantly higher risk than those in 2000–2009. Specifically, those with CCI = 0 had an AHR of 1.77 (95% CI: 1.29–2.41, p = 0.0003), and those with CCI = 1–2 had an AHR of 1.79 (95% CI: 1.23–2.60, p = 0.0026).Fig. 3The subgroup analysis of anxiety or depression risk between 2000–2009 and 2010–2019 The subgroup analysis of anxiety or depression risk between 2000–2009 and 2010–2019 Discussion In this study, we used a large nationwide population-based database to demonstrate a significant increase in the incidence of anxiety and depression among tSCI patients in the more recent decade (2010–2019) compared to 2000–2009. This trend was observed across various demographic and clinical subgroups, suggesting that shifts in population characteristics and healthcare dynamics may contribute to worsening anxiety or depression in tSCI patients. Especially, patients aged 20–34 years show the highest incidence relative risk of anxiety or depression (IRR = 1.90, 95% CI: 1.12–3.22, p = 0.0176) between these two decades, so the early intervention in this group should be required. Additionally, our finding indicated patients with a catastrophic illness card presented a higher overall risk than those without as comparing across the entire study period. However, patients without a catastrophic illness card in 2010–2019 had a higher risk of developing anxiety or depression than those in 2000–2009 (AHR: 1.71, 95% CI: 1.35–2.16, p < 0.0001), potentially reflecting differences in injury severity, healthcare access, or rehabilitation support. These findings emphasize the importance of targeted mental health support and suitable care strategies for different subgroups. Our study indicated that patients with tSCI were older in the more recent decade (2010–2019) compared to 2000–2009, and this may partly be correlated with the rising observed incidence of anxiety or depression in 2010–2019. As Taiwan’s population continues to age, tSCI has become more prevalent among older adults [25, 26]. The primary causes of spinal cord injury in older adults are falls and traffic accidents [25]. Consistent with global epidemiological trends, the proportion of older patients (50–79 years) in the 2010–2019 cohort was higher, reflecting the overall trend shift to population aging [27]. This change may coexist with an increased burden of comorbidities, such as hypertension, renal disease, and diabetes, that have been associated with greater vulnerability to mental health disorders [28, 29]. In addition to aging, other contextual factors may have association with the rising incidence rate of depression or anxiety, including the growing prevalence of social media use and widening income inequality [30, 31]. However, due to the observational study design, causal relationships could not be established. The increasing incidence of depression and anxiety may reflect the potential coexisted association effects of multiple demographical, psychosocial, and societal factors. Further research is required to explore how these broader social determinants interact with tSCI to affect mental health outcomes over time. Our study observed an increase in the incidence of anxiety and depression among tSCI patients, rising from 208.46 to 350.44 per 10,000 person-years, highlighting a critical public health concern. Adjusted analyses revealed that the risk of developing anxiety or depression was 67% higher in the 2010–2019 cohort compared to earlier decade. The increase was observed across all age groups. This pattern indicated that multiple demographic and societal factors may affect this trend. Younger patients (20–34 years) in the 2010–2019 cohort were more susceptible to developing anxiety or depression than they are in the 2000–2009 cohort. This may be attributed to the significant psychological stress younger patients experience following tSCI due to the abrupt disruption of life plans and social roles, a phenomenon consistent with the findings of [5]. Additionally, research suggests that the stigma surrounding mental health issues is lower among younger populations, making them more willing to seek professional help, thereby increasing diagnostic rates [32]. Conversely, older patients (≥ 65 years) also exhibited significant mental health risks due to accumulated health burdens, aligning with the cumulative disadvantage theory in aging [33]. Overall, the rising burden of anxiety and depression in tSCI patients may results from an interplay of demographic, psychosocial, and healthcare-related factors rather than aging alone. Furthermore, female patients were more likely than male patients to develop anxiety and depression, consistent with previous research on gender differences in mental health [34]. Compared to men, women are more susceptible to the psychological impact of traumatic events and tend to exhibit more pronounced emotional symptoms [35, 36]. A large-scale epidemiological study in the United States found that the lifetime prevalence of anxiety disorders in women is approximately twice that in men [37, 38]. These findings underscore the necessity of incorporating gender-sensitive strategies in the psychological care of tSCI patients. Even among cases without additional comorbidities, the incidence of mental health disorders has significantly increased, potentially due to a reduction in family and social support, which can lead to diminished social networks and, consequently, an elevated risk of mental health issues [39]. Additionally, the observed increase in anxiety and depression may partly stem from improved diagnostic recognition and the greater comprehensiveness of medical records [40, 41]. Moreover, across the whole study period, patients holding a catastrophic illness certificate had a 1.51-fold higher risk of developing anxiety or depression compared to those without such certification. This is because, in Taiwan, catastrophic illness certification is granted to patients with an Injury Severity Score (ISS) >16, meaning that individuals with more severe injuries are more profoundly affected both physically and psychologically. This observation is consistent with the arguments presented by Katharine Baecher [42]. In cases where patients sustain permanent disabilities, they must undergo long-term adaptation to a new lifestyle and functional limitations. This prolonged adjustment process may contribute to persistent psychological distress, thereby increasing the risk of anxiety and depression [5]. However, in the subgroup analysis of patients without a catastrophic illness card, our finding indicated 2010–2019 cohort had a higher risk of developing anxiety or depression than 2000–2009 cohort (AHR: 1.71, 95% CI: 1.35–2.16, p < 0.0001). This suggests that, although patients with catastrophic illness certificates remain at the highest absolute risk, the rising trend among less severe cases in recent years warrants clinical attention. Limitation Some limitations in this study should be addressed. First, the claims database used in this study lacks detailed clinical information about the severity and progression of anxiety or depression. The absence of standardized psychiatric assessments, such as symptom severity scales or treatment responses, may lead to an underestimation or misclassification of mental health outcomes. Future research should include validated psychiatric assessment tools and patient-reported outcome measures. Second, we could not distinguish between different levels of tSCI due to the limitations of the database coding system. However, we used patients with a catastrophic illness card as a proxy for severe SCI. In Taiwan, patients who had been issued a catastrophic illness card for SCI were categorized as ISS ≥ 16 by the BNHI [43]. Third, psychosocial factors, such as social support and socioeconomic conditions, were not available in our database. These variables play an important role to affect the risk of developing anxiety or depression risk in post-tSCI periods. Future studies should integrate survey-based or qualitative methods to assess psychosocial determinants and their interaction with clinical factors. Fourth, differences in healthcare access, mental health awareness, and diagnostic practices across the two study periods may affect the observed trends in anxiety or depression. The expansion of psychiatric services and improving diagnostic criteria could increase detection rates in recent years [5]. Additionally, because this was an observational temporal analysis, causal relationships between demographic or social factors and the incidence of depression or anxiety could not be established. Although subgroup analyses were performed to explore consistency across populations, multiple comparisons may increase the likelihood of Type I error. Therefore, these findings should be interpreted carefully, and the future research are required to confirm these associations. Finally, due to Taiwan’s National Health Insurance system shifted from ICD-9-CM to ICD-10-CM in 2016, minor inconsistencies in diagnostic coding may exist between these two decades. Although coding accuracy for anxiety and depression in the NHIRD has been validated [44], potential misclassification bias cannot be excluded. Similarly, the definition of tSCI in this study was based on ICD-9-CM and ICD-10-CM codes that have been widely applied in previous studies using NHIRD [45, 46]. Moreover, the LHID2005 is representative of the general Taiwanese population, individuals who withdrew from the insurance system may not be fully captured, which could introduce minor selection bias. However, the lack of direct clinical validation of tSCI within the NHIRD may also lead a potential risk of misclassification. Despite these limitations, our study provides important information into the changing mental health challenges among tSCI patients, highlighting the need for early intervention and multidisciplinary support strategies. The findings of this study may provide valuable epidemiological information to inform future research on treatment patterns and suicide risk among tSCI patients with depression or anxiety. Conclusion In conclusion, this study underscores the rising burden of anxiety or depression disorders in tSCI patients, especially in younger populations and those without a catastrophic illness card. Moreover, the aging tSCI population and higher comorbidity rates may contribute to the increasing incidence of anxiety or depression. To reduce these risks, early mental health screening, integrated multidisciplinary care, and psychosocial support should be essential to address these challenges effectively and improve long-term outcomes for tSCI survivors.